Precision Medicine and Head & Neck Cancer
What It Means for You
Cancer treatment is not one-size-fits-all. People with head and neck cancer can have very different tumors, even when the cancer starts in the same area. Precision medicine is an approach that helps doctors choose treatments based on the specific features of your cancer, rather than using the same plan for everyone.
The goal is simple:
- Use treatments that are more likely to work for you
- Avoid treatments that are unlikely to help
- Reduce unnecessary side effects when possible
Precision medicine does not replace surgery, radiation, or chemotherapy. It helps doctors decide how and when to use them.
What Is Precision Medicine?
Precision medicine looks at:
- The biology of your tumor
- Certain proteins or markers in cancer cells
- Sometimes, changes in the tumor’s DNA
Doctors use this information to guide decisions about treatment, monitoring, and clinical trials.
You may also hear this called:
- Personalized medicine
- Targeted care
- Biomarker-guided treatment
These terms all describe the same idea: matching treatment to the cancer, not just the diagnosis.
What Are Biomarkers?
Biomarkers are measurable features found in cancer cells, blood, or tissue that give doctors clues about how a cancer behaves.
They can help doctors:
- Understand how aggressive the cancer may be
- Predict how well certain treatments might work
- Decide if immunotherapy or targeted therapy is appropriate
- Identify clinical trial options
Not every person will have biomarkers that change treatment. That does not mean there are no good treatment options.
Common Biomarkers You May Hear About
Some biomarkers are already part of routine care for certain types of head and neck cancer. Others are still being studied.
- HPV can cause some throat and tonsil cancers.
- HPV-related cancers often respond better to treatment.
- p16 is a protein used as a marker to show if a tumor is HPV-related.
- HPV status can affect prognosis and, in some cases, treatment planning.
You may hear:
“Your tumor is p16-positive,” meaning it is likely HPV-related.
- PD-L1 is a protein that helps cancer hide from the immune system.
- High PD-L1 levels can make some people more likely to benefit from immunotherapy.
- PD-L1 testing is most often used when cancer has returned or spread.
You may hear:
“Your PD-L1 score suggests immunotherapy could be an option.”
- EBV is linked to nasopharyngeal cancer.
- Blood tests can measure EBV levels to help monitor treatment response.
- EBV testing is specific to certain cancers and not used for everyone.
- EGFR is a protein involved in cancer growth.
- Some head and neck cancers have high EGFR levels.
- EGFR-targeted drugs may be used in certain situations, but benefits are often modest.
EGFR is one factor among many and is not used alone to make treatment decisions.
What Is biomarker testing?
Biomarker testing looks at the DNA inside cancer cells to find changes that may drive tumor growth or affect treatment response.
Important points:
- This tests the tumor, not the genes you were born with.
- It is different from genetic testing used to assess inherited cancer risk.
- Comprehensive biomarker testing is not routine for all head and neck cancers.
Biomarker testing is most often used:
- When cancer comes back
- When cancer spreads
- When doctors are considering clinical trials
Is Precision Medicine Standard Care?
Some biomarker testing is standard.
Many newer tests are not.
Your care team decides:
- Which tests are helpful
- When testing is appropriate
- Whether results would change treatment
More testing does not always mean better care. In some cases, it adds cost, stress, or delays without changing treatment.
Will Biomarker Testing Change My Treatment?
Sometimes. Not always.
Biomarker results may:
- Help choose immunotherapy or targeted therapy
- Help decide if treatment can be adjusted
- Help determine eligibility for a clinical trial
Even without helpful biomarkers, there are effective treatments available, including surgery, radiation, chemotherapy, and supportive care.
What You Can Do as a Patient or Caregiver?
You do not need to become an expert.
You can ask informed questions.
Consider asking your care team:
- Are any biomarkers being tested for my cancer?
- What do the results mean for my treatment?
- Would additional testing change my care?
- Are there clinical trials I should consider?
If results feel confusing or overwhelming, ask for time and clarification. That is reasonable.
A Note About Research and Emerging Tests
You may read about newer biomarkers, blood tests, or experimental drugs online. Many are promising. Most are still being studied and are not part of routine care.
If a test or treatment is experimental:
- Your doctor should explain why it’s being considered
- Participation is optional
- Standard care remains available
Want to Learn More?
This page provides a general overview.
For a deeper explanation of biomarkers, genomic testing, and emerging research in head and neck cancer, you can download the detailed PDF below.
That document includes:
- More scientific detail
- Research-stage biomarkers
- How doctors interpret complex test results
- Limitations and unanswered questions
